Does Dual Use Jeopardize the Potential Role of Smokeless Tobacco in Harm Reduction?

被引:37
作者
Frost-Pineda, Kimberly [1 ]
Appleton, Scott [1 ]
Fisher, Michael [1 ]
Fox, Kathleen [1 ]
Gaworski, Charles L. [1 ]
机构
[1] Altria Client Serv, Richmond, VA 23219 USA
关键词
MOIST SNUFF; DISEASE; CANCER;
D O I
10.1093/ntr/ntq147
中图分类号
R194 [卫生标准、卫生检查、医药管理];
学科分类号
摘要
The use of smokeless tobacco as part of a strategy to reduce the harm from cigarette smoking is a topic of debate within the tobacco control and public health communities. One concern voiced regarding endorsement of such a tactic is the possibility of actually increasing harm should current smokers adopt dual cigarette/smokeless tobacco use (dual use), which could lead to unintended consequences by perpetuating cigarette smoking, diminishing tobacco cessation, or increasing tobacco-related harm. Here, we review the available literature on health effects and trajectories of use among dual users from a variety of U.S. and European epidemiological studies. These data suggest that there are not any unique health risks associated with dual use of smokeless tobacco products and cigarettes, which are not anticipated or observed from cigarette smoking alone. Furthermore, studies show that dual users smoke fewer cigarettes than exclusive smokers, and studies of tobacco use patterns over time (tobacco use trajectory data) indicate that dual users are more likely than exclusive cigarette smokers to cease smoking. Overall, the concern about dual use appears to be contradicted by the evidence in the literature that dual use of smokeless tobacco and cigarettes may result in reduction in smoking-related harm as smoking intensity is decreased and smoking cessation increases.
引用
收藏
页码:1055 / 1067
页数:13
相关论文
共 22 条
[1]   Chronic disease mortality in a cohort of smokeless tobacco users [J].
Accortt, NA ;
Waterbor, JW ;
Beall, C ;
Howard, G .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (08) :730-737
[2]  
[Anonymous], 2008, HLTH EFF SMOK TOB PR
[3]   Should the health community promote smokeless tobacco (snus) as a harm reduction measure? [J].
Gartner, Coral E. ;
Hall, Wayne D. ;
Chapman, Simon ;
Freeman, Becky .
PLOS MEDICINE, 2007, 4 (07) :1138-1141
[4]   Supping with the Devil? The role of law in promoting tobacco harm reduction using low nitrosamine smokeless tobacco products [J].
Hall, W. ;
Gartner, C. .
PUBLIC HEALTH, 2009, 123 (03) :287-291
[5]   Swedish moist snuff and myocardial infarction among men [J].
Hergens, MP ;
Ahlbom, A ;
Andersson, T ;
Pershagen, G .
EPIDEMIOLOGY, 2005, 16 (01) :12-16
[6]  
*I MED, 2001, CLEAR SMOK
[7]  
*INT AG RES CANC, 2007, MON EV CARC RISKS HU
[8]   Smokeless tobacco and coronary heart disease: a 12-year follow-up study [J].
Johansson, SE ;
Sundquist, K ;
Qvist, J ;
Sundquist, J .
EUROPEAN JOURNAL OF CARDIOVASCULAR PREVENTION & REHABILITATION, 2005, 12 (04) :387-392
[9]  
L T, 2003, CONTROL, V12, P372
[10]   Systematic review of the relation between smokeless tobacco and cancer in Europe and North America [J].
Lee, Peter N. ;
Hamling, Jan .
BMC MEDICINE, 2009, 7 :36